-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

IV Iron Formulations and Use in Adults

Program: Education Program
Session: The Iron Revolution!
Hematology Disease Topics & Pathways:
adult, Clinical Practice (Health Services and Quality), elderly, Therapies, pregnant, Adverse Events, young adult , Study Population, Human, Maternal Health
Sunday, December 10, 2023, 9:30 AM-10:45 AM

Michael Auerbach, MD

Department of Medicine, Auerbach Hem-Onc Associates, Inc., Baltimore, MD

Disclosures: Auerbach: Covis Pharma for Data Management: Research Funding; Pharmacosmos: Honoraria, Other: Educational, Non-promotional programs.

OffLabel Disclosure: Total dose infusion for IV formulations is not approved for most of them. I will be recommending it as my principal method of administraiton.

See more of: The Iron Revolution!
See more of: Education Program